SERA PROGNOSTICS, INC. Gain (Loss) on Extinguishment of Debt
SERA PROGNOSTICS, INC. (SERA) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-22.
Discontinued › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2023-03-22
- SERA PROGNOSTICS, INC. gain (loss) on extinguishment of debt for the quarter ending 2022-12-31 was $0.00.
- SERA PROGNOSTICS, INC. gain (loss) on extinguishment of debt for the quarter ending 2022-09-30 was $0.00.
- SERA PROGNOSTICS, INC. gain (loss) on extinguishment of debt for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- SERA PROGNOSTICS, INC. gain (loss) on extinguishment of debt for the quarter ending 2022-03-31 was $0.00.
- SERA PROGNOSTICS, INC. gain (loss) on extinguishment of debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- SERA PROGNOSTICS, INC. gain (loss) on extinguishment of debt for fiscal 2021 was $1.05M.
- SERA PROGNOSTICS, INC. gain (loss) on extinguishment of debt for fiscal 2020 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $0.00 derived: sum of 2 quarters · filed 2023-03-22 | $0.00 derived: sum of 3 quarters · filed 2023-03-22 | $0.00 10-K · filed 2023-03-22 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 4 quarters · filed 2023-03-22 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-10 | $0.00 10-Q · filed 2022-08-10 | $0.00 derived: sum of 3 quarters · filed 2023-03-22 | $0.00 derived: sum of 4 quarters · filed 2023-03-22 |
| 2022-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2023-03-22 | $0.00 derived: sum of 2 quarters · filed 2023-03-22 | $0.00 derived: sum of 3 quarters · filed 2023-03-22 | $1.05M derived: sum of 4 quarters · filed 2023-03-22 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $0.00 derived: sum of 2 quarters · filed 2023-03-22 | $1.05M derived: sum of 3 quarters · filed 2023-03-22 | $1.05M 10-K · filed 2023-03-22 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $1.05M derived: sum of 2 quarters · filed 2022-11-09 | $1.05M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $1.05M 10-Q · filed 2022-08-10 | $1.05M 10-Q · filed 2022-08-10 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $0.00 derived: sum of 2 quarters · filed 2022-03-29 | $0.00 10-K · filed 2022-03-29 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |